Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus

Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus

Abstract Purpose Neoadjuvant chemoradiation (nCRT) is the treatment of choice for patients with locally advanced squamous cell carcinoma of the esophagus (SCC). Today radiation oncologists can choose between two different therapy regimes including chemoradiation with cisplatin and 5-fluoruracil (CDD...

Full description

Bibliographic Details
Main Authors: Stefan Münch, Steffi U. Pigorsch, Marcus Feith, Julia Slotta-Huspenina, Wilko Weichert, Helmut Friess, Stephanie E. Combs, Daniel Habermehl
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Radiation Oncology
Subjects:
Squamous cell carcinoma of the esophagus
Neoadjuvant chemoradiation
Cisplatin/5-fluoruracil
Carboplatin/Paclitaxel
Online Access:http://link.springer.com/article/10.1186/s13014-017-0904-y

Internet

http://link.springer.com/article/10.1186/s13014-017-0904-y

Similar Items